ERBB3 and breast cancer: In breast cancer cell lines BTK474-HR20 and SKBR3-pool2 selected in vitro for resistance to trastuzumab a strong upregulation of ErbB3, pErbB3, IGF1R and pIGFR is observed which strongly contribute to cell proliferation [58].